longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Gilead Sciences

GILD

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI
Share your thoughts

What's on your mind?

0 / 2,000
  • F
    First FellowJul 20 at 03:55 AM

    • Dow futures fell while oil prices rose due to escalating attacks in Iran.

    • Three U.S. servicemembers were killed in the attacks.

    • Key earnings reports from Google, Tesla, Intel, and GE Vernova are upcoming.

    • Gilead faces challenges with HIV treatments as patent expirations approach.

    • Eli Lilly is highlighted for strong earnings performance and is in a buy zone.

    • Intel prepares for its Q2 earnings report amid a chip market sell-off.

    • Biotech stocks remain attractive to investors despite AI stock declines.

  • F
    First FellowJul 18 at 04:55 PM

    • Gilead Sciences leads in HIV treatments, facing competition from other drug companies. $Gilead Sciences(GILD.US)

    • The stock market is experiencing a sell-off, particularly in AI-related stocks.

    • CrowdStrike is expanding into AI Detection and Response, boosting its stock performance.

    • Upcoming earnings reports from Google, Tesla, and Intel are critical for the AI sector.

    • The semiconductor market is struggling, with chip stocks entering bear territory.

    • Biotech stocks remain strong despite the downturn in AI stocks.

  • F
    First FellowJul 8 at 10:42 PM

    Healthcare is the leader at moment. Not one name. I see a cluster:

    - M&A rocket: $Crinetics Pharmaceuticals(CRNX.US) +116% in July on $Vertex Pharma(VRTX.US) $10B buyout at $85

    - Mega cap momentum: $Eli Lilly(LLY.US) 52 week high, revenue +47%

    - YTD monsters: $Moderna(MRNA.US) +170%, $Gilead Sciences(GILD.US) +5% today

    - Defensive flows: $Johnson & Johnson(JNJ.US) $Unitedhealth(UNH.US) $Welltower Op(WELL.US) all at highs

    Meanwhile $MAGS is bleeds=ing and $XLK is red. The pattern is, institutions are rotating into pharma and biotech.

    Watch the cluster: #UNH $Eli Lilly(LLY.US) $Vertex Pharma(VRTX.US) $Crinetics Pharmaceuticals(CRNX.US) $Moderna(MRNA.US) $Gilead Sciences(GILD.US) $Johnson & Johnson(JNJ.US) $TG Therap(TGTX.US) $Revolution Medicines(RVMD.US)

    Always keep an eye on the sector rotation.

  • S
    Sunrise TraderJan 21 at 08:11 PM

    $Gilead Sciences(GILD.US) breaking out today. None here

    Source: Sunrise Trader